Plenary Speakers

Every year, we invite a number of plenary speakers who are experts in their respective fields. Their talks complement the Symposium sessions by providing a coherent overview on a variety of topics across the ALS/MND research and clinical management spectrum. Click on the images below to find out more about the plenary speakers who will be presenting at the Virtual 33rd International Symposium on ALS/MND. Please note, sessions are provisional so may be subject to change.

DAY 1 - TUESDAY 6 DECEMBER 2022

SESSION 1 - OPENING SESSION

The Stephen Hawking Memorial Lecture
Dr Fred Gage

The Salk Institute for Biological Studies, USA

DAY 2 - WEDNESDAY 7 DECEMBER 2022

SESSION 3 - METABOLISM AND NUTRITION

Prof Shyuan Ngo
The University of Queensland, Australia

 

SESSION 4 - CELL-BASED MODELS

Dr Kasper Roet
QurAlis, USA

 

SESSION 5 - DISEASE PRESENTATION AND RISK

Prof George Davey-Smith
University of Bristol, UK

Dr Carmela Tartaglia
Univeristy of Toronto, Canada

Dr Michael Benatar
Univeristy of Miami, USA

DAY 3 - THURSDAY 8 DECEMBER 2022

SESSION 6 - CELL BIOLOGY AND PATHOLOGY

Prof Janine Kirby
University of Sheffield, UK

SESSION 7 - RNA AND PROTEIN PROCESSING

Prof Heather Durham
Montreal Neurological Institute, McGill University

Prof Eran Hornstein
Weizmann Institute of Science, Israel

DAY 4 - FRIDAY 9 DECEMBER 2022

SESSION 8 - NEUROINFLAMMATION

Dr Jasna Kriz
Université Laval, Canada 

Dr Stanley Appel 
Houston Methodist Research Institute, USA

SESSION 9 - TRIAL DESIGN AND CLINICAL ENDPOINTS

Dr Ruben van Eijk
University Medical Center Utrecht, Netherlands

Dr Toby Ferguson
Biogen, Boston, USA

Stephanie Fradette
Biogen, Boston, USA

SESSION 10 - CLOSING SESSION

Dr Leigh Hochberg
Brown University, USA